Oral malignant melanoma is the most common, but aggressive oral cancer in dogs with poor prognosis. Electrochemotherapy (ECT) has therapeutic potential in such tumors as effective local treatment. Therefore, the aim of this prospective clinical study was to evaluate treatment effectiveness of ECT in as first line treatment for canine oral malignant melanoma, and search for factors influencing treatment outcome
Background: Electrochemotherapy (ECT) promotes the increased uptake of antitumor agents through the ...
Background: Electrochemotherapy (ECT) is a novel anticancer therapy that combines the delivery of tr...
Mast cell tumours (MCTs) are a prominent skin disease commonly diagnosed in dogs
Oral malignant melanoma is the most common, but aggressive oral cancer in dogs with poor prognosis. ...
The aim of this study was to evaluate the safety and efficacy of the combination of electrochemother...
Non-tonsillar squamous cell carcinoma (ntSCC) is a common and locally aggressive oral tumour in dogs...
Critical appraisal of the available literature for the treatment of canine oral malignant melanoma (...
Non-tonsillar squamous cell carcinoma (SCC) is the second most common oral tumor in dogs [1]. It is ...
Electrochemotherapy (ECT) is an innovative antineoplastic treatment based on local application of s...
: Electrochemotherapy (ECT) is a tumor treatment that, through the application of electric pulses wi...
Electroporation is a method of inducing an increase in permeability of the cell membrane through the...
Tumor microenvironment is one of the major obstacles to the efficacy of chemotherapy in cancer patie...
To describe the results of electrochemotherapy (ECT) in dogs with mast cell tumours (MCTs) either as...
Canine anal melanoma is an aggressive neoplasm that rapidly leads to constipation in dogs, thus mimi...
Electrochemotherapy (ECT) is a novel anticancer therapy that is currently being evaluated in human a...
Background: Electrochemotherapy (ECT) promotes the increased uptake of antitumor agents through the ...
Background: Electrochemotherapy (ECT) is a novel anticancer therapy that combines the delivery of tr...
Mast cell tumours (MCTs) are a prominent skin disease commonly diagnosed in dogs
Oral malignant melanoma is the most common, but aggressive oral cancer in dogs with poor prognosis. ...
The aim of this study was to evaluate the safety and efficacy of the combination of electrochemother...
Non-tonsillar squamous cell carcinoma (ntSCC) is a common and locally aggressive oral tumour in dogs...
Critical appraisal of the available literature for the treatment of canine oral malignant melanoma (...
Non-tonsillar squamous cell carcinoma (SCC) is the second most common oral tumor in dogs [1]. It is ...
Electrochemotherapy (ECT) is an innovative antineoplastic treatment based on local application of s...
: Electrochemotherapy (ECT) is a tumor treatment that, through the application of electric pulses wi...
Electroporation is a method of inducing an increase in permeability of the cell membrane through the...
Tumor microenvironment is one of the major obstacles to the efficacy of chemotherapy in cancer patie...
To describe the results of electrochemotherapy (ECT) in dogs with mast cell tumours (MCTs) either as...
Canine anal melanoma is an aggressive neoplasm that rapidly leads to constipation in dogs, thus mimi...
Electrochemotherapy (ECT) is a novel anticancer therapy that is currently being evaluated in human a...
Background: Electrochemotherapy (ECT) promotes the increased uptake of antitumor agents through the ...
Background: Electrochemotherapy (ECT) is a novel anticancer therapy that combines the delivery of tr...
Mast cell tumours (MCTs) are a prominent skin disease commonly diagnosed in dogs